Digital
This report compares expenditure between primary and secondary care in total and for medicines positively appraised by NICE.
On 14 November 2014, an additional Excel file was made available, containing the underlying data from all the Tables and Figures in the report.
The overall NHS expenditure on medicines in 2013-14 was £14.4 billion.
In 2013-14 hospital use accounted for 40.1 per cent of the total cost, up from 37.5 per cent in 2012-13.
The cost of medicines rose by 7.6 per cent overall but by 15.1 per cent in hospitals, from 2012-13 to 2013-14.
Of the drugs positively appraised by NICE, the greatest overall cost in 2013-14 was for Adalimumab, which also incurred the greatest cost in hospitals.